| FAL1 | cervical squamous cell carcinoma | RT-qPCR, Western blot | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 32046419 | 2019 |
| FAL1 | osteosarcoma | qPCR, Western blot, in vitro knockdown | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✔ | ✔ | ✔ | ✘ | ✘ | 29987852 | 2018 |
| FAL1 | oesophageal cancer | qPCR, Western blot | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✔ | ✔ | ✔ | ✘ | 30873881 | 2019 |
| FAL1 | ovarian cancer | RT-qPCR, Western Blot Analysis | L | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 31957817 | 2020 |
| FAL1 | esophageal cancer | qPCR, Luciferase reporter assay, ChIP, Western Blot | H | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | 30178844 | 2018 |
| FAL1 | colon cancer | qPCR, Western blot, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | ✔ | ✘ | 30290064 | 2018 |
| FAL1 | colorectal cancer | qPCR, Western blot, Luciferase reporter assay, Other | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✔ | ✘ | ✘ | 30267804 | 2019 |
| FAL1 | gastric cancer | qPCR, Western blot, etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 30556865 | 2018 |
| FAL1 | esophageal squamous cell carcinoma | qPCR, Western blot, etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | 30501006 | 2018 |
| FAL1 | oral squamous cell carcinoma | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | 31298329 | 2019 |
| FAL1 | papillary thyroid cancer | qPCR, Western blot etc. | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 26825907 | 2016 |
| FAL1 | acute lymphoblastic leukemia | qPCR, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25203321 | 2014 |
| FAL1 | breast cancer | qPCR, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25203321 | 2014 |
| FAL1 | chronic myelogenous leukemia | qPCR, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25203321 | 2014 |
| FAL1 | colon cancer | qPCR, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25203321 | 2014 |
| FAL1 | glioblastoma | qPCR, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25203321 | 2014 |
| FAL1 | large cell immunoblastic lymphoma | qPCR, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25203321 | 2014 |
| FAL1 | melanoma | qPCR, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25203321 | 2014 |
| FAL1 | myeloma | qPCR, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25203321 | 2014 |
| FAL1 | prostate cancer | qPCR, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25203321 | 2014 |
| FAL1 | renal cancer | qPCR, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25203321 | 2014 |
| FAL1 | hepatocellular carcinoma | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc. | H | ✘ | ✔ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 29421439 | 2018 |
| FAL1 | non small cell lung cancer | qPCR, RNA pull-down assay etc. | H | ✘ | ✔ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 25203321 | 2014 |
| FAL1 | ovarian cancer | qPCR, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25203321 | 2014 |
| FAL1 | ovarian cancer | qPCR, RNA pull-down assay etc. | H | ✘ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | 25203321 | 2014 |
| FAL1 | non small cell lung cancer | qPCR, Western blot | H | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✘ | ✔ | ✘ | ✘ | 28854421 | 2017 |
| FAL1 | osteosarcoma | qRT-PCR, Western blot analysis | H | ✘ | ✘ | ✔ | ✘ | ✔ | ✘ | ✘ | ✘ | ✘ | ✘ | 29987852 | 2018 |